AMPK–SQSTM1 Feedback Under Metabolic Stress

Study Background and Research Question

Tumor cells frequently experience glucose limitation, nutrient depletion, reactive oxygen species (ROS), and impaired mitochondrial energy production. These stresses are not independent: reduced nutrient flux can limit NADPH generation and increase oxidative damage, while mitochondrial dysfunction further lowers ATP production. The STK11/LKB1–AMPK pathway helps cells respond by limiting energy consumption and supporting ATP and NADPH homeostasis. In parallel, the KEAP1–NFE2L2/NRF2 pathway induces antioxidant and detoxification programs.

The reference study, published in Autophagy, asks how these pathways communicate during metabolic stress rather than treating them as separate adaptive modules. This question is particularly relevant to non-small cell lung cancer (NSCLC), where STK11/LKB1 and KEAP1 alterations can occur together. The authors investigated whether SQSTM1/p62, a multifunctional autophagy receptor and signaling scaffold, could connect lysosomal stress, AMPK activation, and NRF2 signaling. The central evidence is presented in the reference study.

Key Innovation from the Reference Study

The main innovation is the identification of a double-positive feedback loop between AMPK and SQSTM1. Under metabolic stress, SQSTM1 expression and phosphorylation increased. SQSTM1 then promoted two protective outputs at the same time: degradation of KEAP1 through macroautophagy, which releases NFE2L2/NRF2 activity, and formation of an AXIN–STK11–AMPK complex at the lysosomal membrane, which supports AMPK activation.

The feedback is reciprocal. The study reports that STK11–AMPK activity is also required for the stress-induced increase in SQSTM1 expression and phosphorylation. Thus, AMPK is not merely a downstream energy sensor activated by p62; it helps reinforce the p62 response that sustains both energy adaptation and antioxidant defense. This model explains how one stress-responsive scaffold can synchronize two pathways that are often analyzed separately.

A second conceptual advance is the placement of lysosomal pH and calcium signaling upstream of SQSTM1 regulation. Low glucose metabolism and AMPK-dependent proton reduction caused lysosomal deacidification. The resulting change in lysosomal function promoted PPP2/PP2A-dependent dephosphorylation of TFEB and TFE3, transcription factors that regulate lysosome and autophagy-associated genes, thereby increasing SQSTM1 expression. In parallel, ROS and pH-dependent lysosomal calcium release activated MAP3K7/TAK1, increasing SQSTM1 phosphorylation. This provides a mechanistic chain from metabolic stress to p62-dependent pathway integration.

Methods and Experimental Design Insights

The experimental design is mechanistic rather than purely descriptive. The investigators modeled metabolic stress using low-nutrient or low-glucose conditions and then examined changes in SQSTM1, AMPK, NRF2, KEAP1, lysosomal behavior, and antioxidant responses. The logic of the experiments was to test each link in the proposed pathway: whether p62 is necessary for dual pathway activation, whether AMPK feeds back to p62, and whether lysosomal pH, ROS, calcium, and specific phosphorylation sites are causal.

Readouts included protein expression and phosphorylation, protein-complex or interaction analyses, assessment of KEAP1 turnover, and evaluation of lysosomal signaling components. The study also used perturbations involving lysosomal acidification, ROS, and extracellular protons to distinguish general stress effects from pH-dependent mechanisms. The reported use of bafilomycin A1, concanamycin A, N-acetylcysteine, and lactic acid is especially informative because these interventions probe lysosomal proton handling or oxidative signaling rather than simply measuring endpoint viability.

Protocol Parameters

• Metabolic stress model: Use low-nutrient or low-glucose conditions to examine the coordinated response of AMPK, SQSTM1, KEAP1, and NFE2L2/NRF2; the reference study treats these conditions as a model of tumor-associated metabolic pressure.
• Feedback-loop analysis: Measure both SQSTM1 abundance or phosphorylation and AMPK activation. A one-directional experiment may miss the study’s central finding that AMPK activity is required for reinforcement of the p62 response.
• Lysosomal mechanism: Pair lysosomal acidification or proton-handling perturbations with measurements of AXIN–STK11–AMPK assembly and KEAP1 degradation. This separates lysosomal signaling from nonspecific nutrient stress.
• ROS and calcium controls: Antioxidant intervention and evaluation of lysosomal calcium-dependent TAK1 signaling can help test whether oxidative and ionic signals contribute independently to SQSTM1 phosphorylation.
• Site-specific validation: Include SQSTM1 phosphorylation at S24 and S226 when testing pathway sufficiency or necessity, because the reference study identifies these sites as important for AMPK and NFE2L2 activation.
• Interpretation of lactic acid: Treat proton supplementation as a mechanistic control rather than simply another nutrient condition. In the study, protons supplied by lactic acid abrogated the responses induced by metabolic stress, emphasizing the importance of lysosomal pH.

These parameters are best viewed as a framework for reproducing the study’s logic, not as a substitute for the exact concentrations, exposure times, cell backgrounds, and normalization procedures reported in the full article and its supplementary information.

Core Findings and Why They Matter

First, metabolic stress increased SQSTM1 expression and phosphorylation, and SQSTM1 was necessary for the coordinated activation of both AMPK and NFE2L2/NRF2. This is important because p62 is often discussed primarily as an autophagy receptor. The study instead supports a broader role in which p62 converts lysosomal and metabolic information into transcriptional and kinase responses.

Second, SQSTM1 activated NRF2 by promoting autophagic degradation of KEAP1. Loss of KEAP1 restraint allows NRF2 to induce antioxidant and cytoprotective genes. At the same time, SQSTM1 facilitated AXIN–STK11–AMPK complex formation on the lysosomal membrane. These parallel mechanisms explain how p62 can support both redox protection and energy conservation during nutrient stress.

Third, the feedback loop depended on lysosomal remodeling. Deacidification caused by low glucose metabolism and AMPK-associated proton reduction activated a PP2A-dependent route involving TFEB and TFE3 dephosphorylation, increasing SQSTM1 expression. ROS and pH-dependent secretion of lysosomal calcium activated TAK1, which increased p62 phosphorylation. The convergence of transcriptional and post-translational regulation makes the response more robust than either mechanism alone.

Fourth, phosphorylation of SQSTM1 at S24 and S226 was functionally important for activation of AMPK and NFE2L2. These sites therefore provide experimentally testable nodes for separating p62 scaffold activity from total p62 abundance. The finding also suggests that measuring SQSTM1 protein levels alone may be insufficient when comparing metabolic-stress responses across cancer models.

Functionally, the AMPK–SQSTM1 loop strengthened antioxidant defense and supported tumor growth under metabolic stress. The findings offer a biological explanation for why simultaneous disruption of STK11 and KEAP1 pathways may be tolerated or selected in some tumors: loss of STK11–AMPK signaling could be offset by strong NRF2 activation, while p62-mediated crosstalk may provide additional compensation. However, the paper presents this as a mechanistic possibility rather than proof of the evolutionary sequence that produces co-occurring mutations.

Comparison with Existing Internal Articles

The internal article AMPK–SQSTM1 Feedback in Metabolic Stress summarizes the same central loop and is useful as a concise pathway overview. The reference study adds the experimental resolution behind that summary: lysosomal deacidification links metabolic status to TFEB/TFE3, TAK1 links ROS and lysosomal calcium to p62 phosphorylation, and defined SQSTM1 sites contribute to dual pathway activation.

A second related resource, AMPK–SQSTM1 Feedback Enhances Dual Antioxidant Defense in Tumors, emphasizes the implications for cancer adaptation and STK11–KEAP1 alterations. The primary paper supports that interpretation but also places important boundaries around it: the feedback mechanism was demonstrated under defined cellular stress conditions, and its relevance will depend on tumor genotype, lysosomal state, and the nature of the metabolic microenvironment.

Limitations and Transferability

The study provides a strong mechanistic model, but several questions remain. First, metabolic stress in cultured cells cannot reproduce the spatial gradients of glucose, lactate, oxygen, cytokines, and ROS found in a tumor. The effect of lysosomal pH may also vary with cell lineage and baseline lysosome biogenesis. Second, the demonstration that the loop promotes tumor growth does not by itself establish that every STK11- and KEAP1-altered NSCLC depends on the same circuit.

Third, p62 has multiple binding partners and functions, so changes in its abundance or phosphorylation may affect autophagy, ubiquitin handling, transcriptional regulation, and kinase signaling simultaneously. Site-directed experiments at S24 and S226 improve specificity, but they do not eliminate the possibility of compensatory phosphorylation or context-dependent interactions. Finally, the proposed explanation for co-occurring mutations is inferential. Genomic selection, immune pressure, and treatment history would need to be studied alongside this pathway in patient-derived models or longitudinal tumor samples.

For transferability, the most reliable strategy is to reproduce the causal sequence rather than only the endpoint NRF2 or AMPK signal: verify metabolic stress, assess lysosomal pH-related changes, measure p62 expression and phosphorylation, test KEAP1 turnover and AXIN–STK11–AMPK assembly, and include pathway-specific controls. This approach can reveal whether a model uses the reported feedback loop or reaches antioxidant protection through an alternative route.

Research Support Resources

Why this cross-domain matters, maturity, and limitations

The paper itself concerns metabolic stress, lysosomal signaling, AMPK, SQSTM1, and NRF2 in cancer biology. It does not establish a role for TRPV1 or validate sensory-neuron assays. For separate TRPV1 experiments, researchers can use AMG 9810 (SKU B7018), a selective competitive TRPV1 antagonist reported to block capsaicin-, proton-, heat-, and endogenous-ligand responses. That application is distinct from the AMPK–SQSTM1 mechanism and should not be presented as evidence that AMG 9810 modifies the reference study’s pathway.

In an independent sensory-neuron workflow, AMG 9810 may support sensory neuron signaling studies involving inhibition of capsaicin-induced calcium influx or a CGRP release inhibition assay relevant to pain mechanism research. The product information should be consulted for solvent handling, including AMG 9810 solubility in DMSO, storage, and assay-specific concentration selection. These are practical research uses, not findings of the metabolic-stress paper.